Cargando…

Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome

The pharmacological treatment strategies for acute coronary syndrome (ACS) in recent years are constantly evolving to develop more potent antithrombotic agents, as reflected by the introduction of more novel P2Y(12) receptor inhibitors and anticoagulants to reduce the ischemic risk among ACS patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvarajah, Abi, Tavenier, Anne H., Fabris, Enrico, van Leeuwen, Maarten A. H., Hermanides, Renicus S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573364/ https://www.ncbi.nlm.nih.gov/pubmed/36233469 http://dx.doi.org/10.3390/jcm11195605

Ejemplares similares

Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
por: Selvarajah, Abi, et al.
Publicado: (2023)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
por: Hommels, Tobias Michiel, et al.
Publicado: (2023)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021)

Large anterolateral ST-elevation myocardial infarction in a patient with an isolated type R-I single coronary artery: a case report
por: Duijvelshoff, Renee, et al.
Publicado: (2021)

Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial
por: Tavenier, Anne H., et al.
Publicado: (2021)

Single-staged transfemoral transcatheter aortic valve implantation and percutaneous coronary intervention with rotablation in complex coronary artery disease: a case report
por: Postma, Warner R, et al.
Publicado: (2018)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021)

A rare but devastating cause of cardiac tamponade
por: Hermanides, R. S., et al.
Publicado: (2019)

Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
por: Barriuso, Ignacio, et al.
Publicado: (2022)

New Paradigms in Antithrombotic Strategies: A Leap into the Future of Cardiovascular Medicine
por: Romiti, Giulio Francesco
Publicado: (2022)

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy
por: Gao, Mingxin, et al.
Publicado: (2023)

Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Optimal pharmacological therapy in ST-elevation myocardial infarction—a review: A review of antithrombotic therapies in STEMI
por: Hermanides, R. S., et al.
Publicado: (2018)

Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
por: Caracciolo, Alessandro, et al.
Publicado: (2019)

Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options
por: Chan Pin Yin, D. R. P. P., et al.
Publicado: (2021)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()
por: Gupta, Kartik, et al.
Publicado: (2019)

Antithrombotic therapy in an experimental model of acute ischemic stroke in rabbits
por: Segura, V, et al.
Publicado: (2004)

Use of Antithrombotics after Hemorrhagic Transformation in Acute Ischemic Stroke
por: Kim, Joon-Tae, et al.
Publicado: (2014)

The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection
por: Bouchlarhem, Amine, et al.
Publicado: (2022)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
por: Canonico, Mario Enrico, et al.
Publicado: (2023)

Marine Antithrombotics
por: Dwivedi, Rohini, et al.
Publicado: (2020)

Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events
por: Olie, R. H., et al.
Publicado: (2021)

Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy
por: Simonsson, Moa, et al.
Publicado: (2022)

Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy
por: Yokota, Hajime, et al.
Publicado: (2008)

Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
por: Nishtala, Prasad S., et al.
Publicado: (2019)

Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
por: James, Stefan
Publicado: (2013)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
por: Weng, Yunqi, et al.
Publicado: (2017)

Editorial: Advances in predicting future adverse coronary events: the role of cardiovascular imaging and coronary physiology indices
por: Seitun, Sara, et al.
Publicado: (2023)

Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol
por: Meijers, Thomas A, et al.
Publicado: (2020)

Coronary Artery Calcification, Epicardial Fat Burden, and Cardiovascular Events in Chronic Obstructive Pulmonary Disease
por: Gaisl, Thomas, et al.
Publicado: (2015)

Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients
por: Yang, Junjie, et al.
Publicado: (2019)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2
por: Tanaka, Kanta, et al.
Publicado: (2022)

Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial
por: Gimbel, Marieke E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3fah93a7j4m89a2gmbn0nfbgqe